Pulse Biosciences, Inc. PLSE Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -10,392.1%+11,590pp | -21,982.6%+69,816pp | -91,798.8%— | —— | —— | |
| Net margin | -9,929%+10,866pp | -20,794.6%+66,104pp | -86,898.8%— | —— | —— | |
| Returns | ||||||
| Return on equity | -80.7%-6.3pp | -74.4%+12.5pp | -87%+16.5pp | -103.5%-25.6pp | -77.9%-10.6pp | |
| Return on invested capital | -1,211.5%-43.4pp | -1,168.1%-26.9pp | -1,141.3%-227pp | -914.4%-209pp | -705.7%+51.4pp | |
| Efficiency | ||||||
| Asset turnover | 0×0.0× | 0×0.0× | 0×— | 0×— | 0×— | |
| Liquidity | ||||||
| Current ratio | 7.3×-3.3× | 10.5×+0.5× | 10×-2.0× | 12×-3.5× | 15.6×+3.7× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Valuation | ||||||
| Market capitalization | $1.47B+57.8% | $930.45M-21.9% | $1.19B+15.0% | $1.04B-2.3% | $1.06B-1.0% | |
| Price / sales | 1,954.6×-704× | 2,658.4×-11,192× | 13,850.4×— | —— | —— | |
| Price / book | 22.1×+10.6× | 11.5×-1.3× | 12.9×+2.9× | 9.9×+1.0× | 9×-0.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pulse Biosciences, Inc.'s profit margins?
- Pulse Biosciences, Inc. (PLSE) runs a -4067.5% gross margin and a -10392.1% operating margin, with a -9929.0% net margin.
- Where do Pulse Biosciences, Inc.'s ratios come from?
- Every ratio is computed from Pulse Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
